Predict your next investment

HEALTHCARE | Drug Discovery

See what CB Insights has to offer

Founded Year



Acquired | Acquired



About AliveGen - Neuromuscular Assets

AliveGen is a privately held clinical-stage biopharmaceutical company. AliveGen focuses on the discovery and development of novel biotherrapeutics to combat the debiltating muscle and bone loss and the loss of functional capactiy, as occurs in various neuromuscular diseases, cancer cachexia, congestive heart failure, geriatric sarcopenia and frailty, as well as in other chronic diseases.

AliveGen - Neuromuscular Assets Headquarter Location

810 Lawrence Dr Suite 120

Newbury Park, California, 91320,

United States

(805) 480-9600

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing AliveGen - Neuromuscular Assets

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

AliveGen - Neuromuscular Assets is included in 2 Expert Collections, including Cancer.



4,844 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.



2,144 items

Companies developing products that monitor, analyze, protect, or otherwise influence the structure/function of the nervous system.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.